In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
Delivery technologies for oral, topical and transdermal products which could be applicable to the consumer healthcare arena More
Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
OTC products ready for registration or in late stage development and molecules with Rx-to-OTC switch potential. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jul 2011 - 206 pages - $500
Jan 2011 - 57 pages - $500
Jan 2011 - 124 pages - $1,740
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Jun 2009 - 472 pages - $3,140
Jun 2008 - 175 pages - $3,835
Nov 2010 - 428 pages - $2,695
Oct 2010 - 97 pages - $3,835
Your selection
Browse By
- Industry sector
- Liquid
- Sustained release
- Tablet
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us